As part of the AMR Multi-Stakeholder Partnership Platform monthly updates, we feature perspectives from experts on critical issues, progress, and key initiatives in our joint efforts against antimicrobial resistance (AMR).
This month, we spoke with Hon. S. Niranjan Reddy, Member of Parliament from India, UNITE Parliamentarians Network for Global Health, about the role of parliamentarians in addressing antimicrobial resistance.
Hon. Reddy, despite broad recognition of the need to address AMR across sectors, progress remains slow while the threat continues to grow. You recently introduced a Private Member’s Resolution on AMR in the Rajya Sabha. What motivated you to bring AMR onto the parliamentary agenda in India, and what concrete policy changes do you hope this resolution will catalyze, both nationally and globally?
It is a stark reality that AMR threatens to undo a century of modern medical progress. As a public representative, I increasingly read about cases where routine infections are becoming difficult and sometimes impossible to treat.
AMR is already associated with over 1.2 million deaths annually, and the burden is projected to rise sharply. It is therefore a threat to economic stability, food systems, and national security.
The Private Member’s Resolution was an effort to elevate AMR from a scientific discussion to a top-tier political priority.
In one of your interventions, you described AMR as a “silent pandemic” requiring cross-sectoral action under a One Health approach. In your view, what unique role can parliamentarians play in accelerating national and international responses to AMR across sectors?
The phrase 'silent pandemic' accurately captures the insidious nature of AMR; it does not command the immediate panic of a novel virus, yet its long-term impact is equally, if not more, catastrophic.
I see that the parliamentarians can play a unique and powerful role. We can be the bridge between scientific consensus and actionable policy.
Equally important is our role in budgetary oversight. Policies without funding remain ineffective. Parliamentarians can ensure that the Health initiatives are backed by sustained financial commitments and measurable targets.
The 2024 United Nations General Assembly High-Level Meeting on Antimicrobial Resistance marked an important milestone in global political commitment to tackling AMR, and the next high-level ministerial meeting on AMR will take place in June 2026. How can global platforms such as the UNITE Parliamentarians Network for Global Health and the AMR Partnership Platform help bridge the gap between political commitments and real-world implementation? How can opportunities such as the upcoming ministerial meeting be leveraged to accelerate progress?
The 2024 UN General Assembly High-Level Meeting established an important baseline of global political commitment on antimicrobial resistance. However, declarations on paper do not save lives automatically. The true measure of progress lies in implementation.
In this regard, global platforms such as the UNITE and the AMR Partnership Platform play a critical role. They help bridge the gap between intent and action by fostering sustained engagement beyond high-level declarations. This ensures that countries are not working in isolation but are instead drawing from a collective pool of legislative knowledge and experience.
At the same time, the AMR Partnership Platform strengthens coordination across sectors, offering the technical guidance necessary to operationalize the One Health approach.
The upcoming ministerial meeting in June 2026 must therefore be approached not merely as another forum for reaffirming commitments, but as a milestone for accountability. Only through such sustained legislative engagement and accountability can we ensure that global commitments translate into tangible outcomes on the ground.